In vitro modulation of human neutrophil superoxide anion generation by various calcium channel antagonists used in ischemia-reperfusion resuscitation

Biochemical Pharmacology

Volumn 38, Issue 20, 1989, Pages 3601-3610

  Zimmerman, Jerry J ^a   Zuk, Susan M ^a   Millard, June R ^a  

^a University of Wisconsin Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUNARIZINE; FREE RADICAL; LACTATE DEHYDROGENASE; LIDOFLAZINE; NICARDIPINE; NIMODIPINE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; VERAPAMIL;

CYTOTOXICITY; DRUG CONCENTRATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL;

ADULT; CALCIUM; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NADH, NADPH OXIDOREDUCTASES; NEUTROPHILS; REPERFUSION INJURY; RESUSCITATION; SUPEROXIDES;

EID: 0024437249     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(89)90133-0     Document Type: Article

References (52)

1. Oxygen-derived free radicals in post-ischemic tissue injury
2. The role of oxygen free radicals in human disease processes
3. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period
4. Pulmonary oxygen toxicity and ischemia-reperfusion injury
5. Role of neutrophils in ischemia-reperfusion-induced microvascular injury
6. Oxidants from phagocytes: agents of defense and destruction
7. Oxy-radicals and related species: their formation, lifetimes, and reactions
8. The roles of extracellular and intracellular calcium in lysosomal enzyme release and Superoxide anion generation by human neutrophils
9. 2+ of catalytic activity of the superoxide-producing NADPH oxidase in membrane fractions of human neutrophils and monocytes
10. Optimal conditions for simultaneous purification of mononuclear and poly-morphonuclear leukocytes from human blood by the Hypaque-Ficoll method
11. Examination of the enzyme assay for NADPH oxidoreductase; application to polymorphonuclear leukocyte Superoxide anion generation
12. Metal-loenzymes and myocardial infarction
13. Preparation and assay of Superoxide dismutases
14. The pathogenesis of irreversible cell injury in ischemia
15. Post-cardiac arrest therapy: calcium entry blockade and brain resuscitation
16. Possible role of calcium blockers in cerebral resuscitation: a review of the literature and synthesis for future studies
17. Prevention of postischemic hypoperfusion after canine cardiac arrest by nicardipine
18. A controlled trial of nimodipine in acute ischemic stroke
19. Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs
20. Amelioration of ischaemic brain damage by postischaemic treatment with flunarizine
21. Role of antioxidants in organ preservation and transplantation
22. Deferoxamine reduces neutrophil-mediated free radical production during cardio-pulmonary bypass in man
23. Myocardial ischemia and reperfusion: Direct evidence for free radical generation by electron resonance spectroscopy
24. Chemiluminescence in hypoxic brain—The first report. Correlation between energy metabolism and free radical reaction
25. Production of free radicals and lipid peroxides in early experimental myocardial ischemia
26. Superoxide production in experimental brain injury
27. Role of free radicals in ischemic rat liver cell injury: Prevention of damage by α-tocopherol administration
28. Free radicals and tissue injury
29. Absorption, excretion and metabolism of a new dihydro-pyridine diester cerebral vasodilator in rats and dogs
30. Pharmacokinetics of nicardipine following oral and intravenous administration in man
31. Brain extraction of a calcium channel blocker
32. Cerebral arterial spasm — a controlled trial of nimodipine in patients with sub-arachnoid hemorrhage
33. Nimodipine
34. Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine and nimodipine
35. Differences in cardiovascular profile among calcium antagonists
36. Studies on the possible mechanisms of lidoflazine arrhythmogenicity
37. Radical scavenging action of flunarizine in rat brain in vitro
38. Clinical relevance of verapamil plasma levels in stable angina pectoris
39. Lag period for Superoxide anion generation and lysosomal enzyme release from human neutrophils: effects of calcium antagonists and anion channel blockers
40. Generation of Superoxide radicals by human peripheral neutrophils activated by chemotactic factor. Evidence for the role of calcium
41. 2+ changes, cyclic AMP and protein kinase
42. Influence of drugs that block calcium channels on the microbicidal function of human neutrophils
43. The effect of verapamil and other calcium antagonists on chemotaxis of poly-morphonuclear leukocytes
44. Verapamil impairs human neutrophil chemotaxis by a non-calcium-mediated mechanism
45. Calcium channel antagonist induced inhibition of superoxide production in human neutrophils. Mechanisms independent of antagonizing calcium influx
46. Nislodipine inhibits formyl-methionyl-leucyl-phenylalanine (f met-leu-phe) receptor-coupled calcium transport in human neutrophils
47. The interference of T cell activation by calcium channel blocking agents
48. Inhibition of macrophage activation by calcium channel blockers and calmodulin antagonists
49. Influence of calcium-channel blockers on platelet function and arachidonic acid metabolism
50. Mechanism of action of calcium-channel-blocking agents
51. Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin
52. Inhibition of calmodulin-dependent cyclic nucleotide phospho-diesterase by flunarizine, a calcium-entry blocker